Sarecycline: A Review of Preclinical and Clinical Evidence

Sarecycline is a tetracycline-derived oral antibiotic, specifically designed for acne, and is approved by the Food and Drug Administration (FDA) in 2018 for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris (AV) in patients 9 years of age and older. It has been de...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, Angela Yen, Del Rosso, James, Johnson, Jodi L, Grada, Ayman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431453/
https://www.ncbi.nlm.nih.gov/pubmed/32884318
http://dx.doi.org/10.2147/CCID.S190473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431453/
https://www.ncbi.nlm.nih.gov/pubmed/32884318
http://dx.doi.org/10.2147/CCID.S190473

Ejemplares similares